Literature DB >> 23824638

Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).

Juan P Rodrigo1, Daniëlle A M Heideman, Juana M García-Pedrero, Manuel F Fresno, Ruud H Brakenhoff, Juan P Díaz Molina, Peter J F Snijders, Mario A Hermsen.   

Abstract

Recent studies support an important role for human papillomavirus (HPV) in oropharyngeal squamous cell carcinomas (OPSCC), although the incidence varies widely depending on the geographic location and time period studied. The aim of this study was to determine the proportion of HPV in a large cohort of OPSCC in northern Spain in the years 1990-2009. Clinical records and paraffin embedded tumor specimens of 248 consecutive patients surgically treated for OPSCC (140 tonsillar and 108 base of tongue) between 1990 and 2009 were retrieved. OPSCC cases were histomorphologically evaluated, and protein expression of p16 and p53 was analyzed by immunohistochemistry. Detection of high-risk HPV DNA was performed by GP5+/6+-PCR and in situ hybridization (ISH). Thirty cases (12%) were positive for p16 immunostaining, of which eight (3.2% of the total series) were found positive for HPV type 16 by genotyping of GP5+6+-PCR products. All HPV GP5+/6+-PCR-positive tumors were p53-immunonegative, seven had a basaloid morphology and seven were also positive by HPV ISH. Presence of HPV correlated inversely with tobacco and alcohol consumption (p < 0.001), but not with age of onset of OPSCC. Overall survival was better in the HPV-positive group, although not statistically significant (p = 0.175). OPSCC patients in northern Spain demonstrated a low involvement of HPV, increasing (although not significantly, p = 0.120) from 1.8% in 1990-1999 to 6.1% of cases in 2000-2009.
© 2013 UICC.

Entities:  

Keywords:  PCR; human papillomavirus; immunohistochemistry; in situ hybridization; oropharyngeal squamous cell carcinoma

Mesh:

Substances:

Year:  2013        PMID: 23824638     DOI: 10.1002/ijc.28355

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

Review 1.  Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic Review.

Authors:  Andrew P Stein; Sandeep Saha; Jennifer L Kraninger; Adam D Swick; Menggang Yu; Paul F Lambert; Randall J Kimple
Journal:  Cancer J       Date:  2015 May-Jun       Impact factor: 3.360

Review 2.  Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.

Authors:  Maura L Gillison; Anil K Chaturvedi; William F Anderson; Carole Fakhry
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

3.  Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.

Authors:  Guro Haugen Fossum; Agnes Kathrine Lie; Peter Jebsen; Lars Erik Sandlie; Jon Mork
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-20       Impact factor: 2.503

4.  HPV status and therapeutic initial strategy impact on survival and oncologic outcomes: 5-year results from the multicentric prospective cohort of oropharyngeal cancers Papillophar.

Authors:  Dorian Culié; Alexandra Rousseau; Jean-Luc Pretet; Jean Lacau Saint Guily
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-10-18       Impact factor: 2.503

5.  Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe.

Authors:  Jordi Rubió-Casadevall; Elna Ciurana; Montserrat Puigdemont; Arantza Sanvisens; Jordi Marruecos; Josefina Miró; Antoni Urban; Rosa-Lisset Palhua; Ferran Martín-Romero; Maria Rosa Ortiz-Duran; Rafael Marcos-Gragera
Journal:  Int J Environ Res Public Health       Date:  2022-04-15       Impact factor: 4.614

6.  Prevalence of human papillomavirus in oral squamous cell carcinomas in northern Spain.

Authors:  Tania Rodríguez-Santamarta; Juan Pablo Rodrigo; Juana M García-Pedrero; Saúl Álvarez-Teijeiro; M Ángeles Villaronga; Laura Suárez-Fernández; Marta E Alvarez-Argüelles; Aurora Astudillo; Juan Carlos de Vicente
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-24       Impact factor: 2.503

7.  Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status.

Authors:  Annekatrin Coordes; Klaus Lenz; Xu Qian; Minoo Lenarz; Andreas M Kaufmann; Andreas E Albers
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-31       Impact factor: 2.503

8.  Characterization of three novel human papillomavirus types isolated from oral rinse samples of healthy individuals.

Authors:  Erin Martin; Juliet Dang; Davit Bzhalava; Joshua Stern; Zoe R Edelstein; Laura A Koutsky; Nancy B Kiviat; Qinghua Feng
Journal:  J Clin Virol       Date:  2013-11-01       Impact factor: 3.168

9.  Elective neck dissection during salvage surgery after radiotherapy in patients with head and neck squamous cell carcinoma.

Authors:  G Pedemonte; E Esteller; J-C Villatoro; J-M Costa; C Valero; M Quer; X León
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

Review 10.  Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?

Authors:  Stuart E Samuels; Avraham Eisbruch; Jonathan J Beitler; June Corry; Carol R Bradford; Nabil F Saba; Michiel W M van den Brekel; Robert Smee; Primož Strojan; Carlos Suárez; William M Mendenhall; Robert P Takes; Juan P Rodrigo; Missak Haigentz; Alexander D Rapidis; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-13       Impact factor: 3.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.